Trial intelligence / Profile preview

Celecoxib for gastric precancerous lesions in Helicobacter pylori-infected chronic atrophic gastritis

ChiCTR-TNRC-08000150Phase 4Completed

Sponsor
West China Hospital of Sichuan University
Start
Jul 2007
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of celecoxib in atrophic gastritis (AG), gastric preneoplasia and Helicobacter pylori infection (3 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: Biochemical indicators and Histological indicators. Started Jul 2007; status: completed.

02

Drugs

celecoxib
03

Conditions

atrophic gastritis (AG)gastric preneoplasiaHelicobacter pylori infection

Beyond the preview

Go deeper on ChiCTR-TNRC-08000150.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TNRC-08000150.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call